Tags: ADAM Sensor | Aterica | Belty | BlackBox Biometrics | BlueMaestro | Bragi | Cambridge Consultans | CES2015 | Consumer Physics | Dash | Emiota | GoBe | Gymwatch | Healbe | Health Care Originals | health sensing earbuds | iSwim Band | Lenovo VIBE Band | Linx IAS | MeloMind | Misfit | myBrain | Neo | NeuroMetrix | Pacif-i | Quell | Quitbit | SCiO | Sensoria Smart Socks | SKE Labs | smart belt | smart EpiPen case | Swarovski Collection | Veta | XelfleX | Zensorium | Zensorium Being |
By: The MobiHealthNews Team
By the end of CES15 MobiHealthNews has tracked more than 40 health device makers who either unveiled or launched products, announced updated pricing or new features for already known ones. If you missed our first roundup of health devices from CES15 — be sure to check them out here. Read on for another 19 digital health device makers who made news at CES15 in Las Vegas this week.
Aterica announced that their first product, a smartphone-connected case for an EpiPen, called Veta, is open for pre-orders. The case has a flashing light and audio alerts that can help the user locate the EpiPen if it’s been misplaced. Veta also has a proximity alert that will tell users via their mobile device if they left the case behind. Users can customize the proximity alerts by providing flexibility if they are in low-risk locations, like their home. Temperature sensors in the case can alert the user if the EpiPen gets too hot or too cold and if the user has an allergic reaction and take the cap off the smart case, an alert will be sent to caregivers in the user’s network. Keep reading>>
Tags: CES | CES 2015 | Mobile Enabled Clinical Trials | Novartis | Novartis Trials of the Future | Qualcomm | Qualcomm Life | Qualcomm Life 2net | Walgreens |
Qualcomm’s 2net Hub
Qualcomm Life announced two major partnerships at CES15 this year: one with pharmaceutical company Novartis and the other with pharmacy chain Walgreens.
Novartis selected Qualcomm Life as a partner for its global Trials of the Future program, in which Novartis is endeavoring to use more mobile technology in its clinical trials and to provide connectivity for future Novartis products. Novartis will use Qualcomm Life’s 2net platform and various connected devices to collect medical data directly from trial participants in their homes.
“Novartis is a pioneer in putting technology to use in advancing pharmaceutical innovation,” Rick Valencia, senior vice president and general manager of Qualcomm Life said in a statement. “Standardizing on the tech-agnostic 2net Platform and accessing the robust ecosystem of integrated medical devices will provide them a great range of flexibility and scalability, ultimately accelerating their efforts to design more efficient, cost-effective clinical trials.”
The first trial in the new partnership has already begun, evaluating the use of mobile devices for patients with chronic lung conditions. The trial is observational and doesn’t involve any Novartis products or other pharmaceuticals. According to Qualcomm, the study “leverages 2net mobile-enabled smartphones and 2net Hubs to seamlessly collect and aggregate biometric data from medical devices and transmits this data to the cloud-based 2net Platform, which securely sends the data to the study coordinator.” Keep reading>>
Tags: CafeWell | CafeWell Health Optimization Platform | Catholic Health Initiatives | Hearst Ventures | WellTok |
Denver, Colorado-based Welltok raised $12 million co-led by Hearst Ventures and Catholic Health Initiatives. The capital tops off a $37 million round for the company, which disclosed the other $25 million in October.
The previous $25 million was led by Bessemer Venture Partners with participation from Emergence Capital Partners, InterWest Partners, New Enterprise Associates (NEA), and Qualcomm Ventures. Welltok’s funding for the past year has reached $59 million — the company’s total disclosed funding now stands at around $72.7 million.
“With the capital raised in 2014, we are in a great position to deliver excellence to our existing and growing client portfolio,” Welltok CEO Jeff Margolis said in a statement. “It also enables us to focus on building new capabilities into our groundbreaking Health Optimization Platform.”
Welltok has developed an online and mobile platform called CafeWell, which curates health management programs, apps, and tracking devices. CafeWell is only available through employers, health plans, or providers. The platform provides users with a personalized health plan including articles, videos, and condition management programs. CafeWell also encourages patients with rewards after reaching health goals and connects patients with coaches and health experts when they need help. Keep reading>>
Tags: Aberdare | clinical trial platform | EDBI | goBalto | Novartis | Qualcomm Health | Shire | West Health |
Software company goBalto has raised $12 million for its software-as-a-service clinical research platform, according to an SEC filing. This brings the company’s total funding to at least $30 million to date.
Existing goBalto investors include Aberdare, West Health, EDBI, and Qualcomm Health.
GoBalto’s main product, Activate (formerly Tracker 2.0), offers clinicians a clinical research platform for “study startup”, which is the process of collecting, reviewing, and approving hundreds or thousands of clinical documents needed in a clinical trial. Tracker 2.0 also helps researchers track milestones during a trial, provide document workflow management, and create a to-do list of required activities. Keep reading>>
Tags: BlackBerry | CES 2015 | NantHealth | NantHealth HBox | NantOmics Cancer Genome Browser |
BlackBerry and NantHealth are working together to create the second generation of NantHealth’s HBox, a portable device that captures and transmits secure medical data between the patient, doctor and hospital. It will use technology from QNX Software Systems, a subsidiary of BlackBerry.
“With HBox, we have created a ‘human signal’ capturing device that automatically and securely transmits, through our HIPAA-compliant ‘NantCloud,’ critical medical data and vital signs to the mission control center,” Dr. Patrick Soon-Shiong, founder and CEO of NantHealth, said in a statement. “Instantly and safely connecting the patient with the doctor and hospital allows for a higher quality of healthcare, expediting diagnosis and treatment, as well as more efficiently and accurately providing vital information into the hands of those in need.”
The first generation of HBox is already in 250 hospitals and transmits 3 billion vital signs annually according to the companies. But what BlackBerry’s partnership will add to the equation is enterprise mobility security. Over the next few months, the device will be incorporated with BlackBerry’s BES enterprise mobility management platform, which will allow HIPAA-compliant encryption of medical data and compatibility with a range of legacy computers and other devices running in hospitals.
“Combining BlackBerry’s embedded software reliability, mobile device management and security technology with NantHealth’s ability to develop leading health care devices and platform creates a powerful strategic relationship,” John Chen, Executive Chairman and CEO of BlackBerry, said in a statement. “We look forward to continued collaboration where we leverage our respective strengths to improve patient healthcare.” Keep reading>>